March 18, 2009
Scientists Identify Potential Tumor Suppressor
The gene Myc is an important factor for the growth of organisms by cell division. It causes the production of a protein which, as a transcription factor, controls the expression of up to 15 % of all human genes. When this gene mutates to an oncogene, the cell proliferates excessively and apoptosis is inhibited. Thereby the gene plays a decisive role in the development of many tumors. The problem is that pharmacological substances do not target Myc as it does not have enzymatic activity of its own. Thus, scientists worldwide are trying to find alternative ways to inhibit this oncogene. A team of scientists led by Klaus Bister and Markus Hartl of the Institute of Biochemistry and the Centre for Molecular Biosciences of the University of Innsbruck may have made an important step towards achieving this goal.
Suppressing pathological cell growth
The team of Bister published the findings in the online edition of the American journal Proceedings of the National Academy of Sciences (PNAS). The scientists are supported by the Austrian Science Fund.
Image 1: Oncogen Myc induces cell transformation (left), tumor suppressor BASP1 inhibits Myc induced cell transformation (right). Credit: University of Innsbruck
Image 2: Dr. Markus Hartl (left) and Professor Klaus Bister (right) from the Institute of Biochemistry at the University of Innsbruck, Austria. Credit: University of Innsbruck
On the Net: